|
Volumn 348, Issue 13, 2003, Pages
|
Management of latent tuberculosis infection in immigrants.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFRICA;
AIDS RELATED COMPLEX;
ETHNOLOGY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEGAL ASPECT;
MIGRATION;
NOTE;
TUBERCULOSIS;
UNITED STATES;
COST BENEFIT ANALYSIS;
HEALTH CARE COST;
AFRICA;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
EMIGRATION AND IMMIGRATION;
HIV INFECTIONS;
HIV-1;
HUMANS;
TUBERCULOSIS;
UNITED STATES;
ANTITUBERCULAR AGENTS;
COST-BENEFIT ANALYSIS;
HEALTH CARE COSTS;
PYRAZINAMIDE;
RIFAMPIN;
PYRAZINAMIDE;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
|
EID: 0037468948
PISSN: None
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJM200303273481317 Document Type: Note |
Times cited : (5)
|
References (0)
|